share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

Arcutis Biotherapeutics | 4:持股變動聲明-高管 Matsuda Masaru
美股SEC公告 ·  11/19 16:56

Moomoo AI 已提取核心訊息

Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], engaged in stock transactions as detailed in recent filings. On November 18, 2024, Matsuda acquired 4,875 shares of common stock at no cost, which was reported as a grant, award, or other acquisition. The following day, November 19, 2024, Matsuda sold 1,775 shares of common stock in the open market at a price of $9.6847 per share, totaling approximately $17,190.34 in market value. After these transactions, Matsuda's direct holdings in Arcutis Biotherapeutics amounted to 181,373 shares. The transactions are currently reported as in progress.
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], engaged in stock transactions as detailed in recent filings. On November 18, 2024, Matsuda acquired 4,875 shares of common stock at no cost, which was reported as a grant, award, or other acquisition. The following day, November 19, 2024, Matsuda sold 1,775 shares of common stock in the open market at a price of $9.6847 per share, totaling approximately $17,190.34 in market value. After these transactions, Matsuda's direct holdings in Arcutis Biotherapeutics amounted to 181,373 shares. The transactions are currently reported as in progress.
Matsuda Masaru,與arcutis biotherapeutics有關的公司[ARQT],參與了最近提交的股票交易。2024年11月18日,Matsuda無償收購了4,875股普通股,報告爲授予、獎勵或其他取得。次日,2024年11月19日,Matsuda以每股9.6847美元的價格,以總價約17,190.34美元在公開市場上出售了1,775股普通股。這些交易後,Matsuda在arcutis biotherapeutics的直接持股達到181,373股。這些交易目前被報告爲進行中。
Matsuda Masaru,與arcutis biotherapeutics有關的公司[ARQT],參與了最近提交的股票交易。2024年11月18日,Matsuda無償收購了4,875股普通股,報告爲授予、獎勵或其他取得。次日,2024年11月19日,Matsuda以每股9.6847美元的價格,以總價約17,190.34美元在公開市場上出售了1,775股普通股。這些交易後,Matsuda在arcutis biotherapeutics的直接持股達到181,373股。這些交易目前被報告爲進行中。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息